Pancreatic Neuroendocrine Neoplasm clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

    open to eligible people ages 18 years and up

    This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)

    San Francisco, California and other locations

Our lead scientists for Pancreatic Neuroendocrine Neoplasm research studies include .

Last updated: